Arcutis Biotherapeutics (ARQT) Return on Sales [ROS] (2022 - 2026)
Arcutis Biotherapeutics (ARQT) recorded Return on Sales [ROS] of 12.65% in Q2 2026, up 30.58 percentage points from -17.93% a year earlier and up 21.27 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Return on Sales [ROS] (2022 - 2026) Analysis & Trends
On a TTM basis, Arcutis Biotherapeutics' Return on Sales [ROS] came in at 7.38% as of Jun 30, 2026, up 39.96 percentage points year-over-year; for FY2025, it came in at -3.25%, up 62.08 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for three straight years, with a three-year change of +8179.79 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -65.33% in FY2024 (+339.16 pp), -404.49% in FY2023 (+7778.55 pp) and -8183.04% in FY2022.
- Quarterly Return on Sales [ROS] has ranged from -14448.00% in Q3 2022 to 14.20% in Q4 2025 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for 12 consecutive quarters, with an average year-over-year change of +100.25 percentage points over the last eight quarters.
- The year-over-year gain in Return on Sales [ROS] has ranged between 9.55 percentage points (Q3 2024) and 14351.16 percentage points (Q3 2023) over the last five years.
- Per Business Quant, the preceding three quarters came in at -8.62% (Q1 2026), 14.20% (Q4 2025) and 8.59% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Arcutis Biotherapeutics | 3.45 Bn | 2.51 Bn | 131.46 Mn | 6.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.56% |
| Jun 30, 2026 | 12.65% |
| Mar 31, 2026 | -8.62% |
| Dec 31, 2025 | 14.20% |
| Sep 30, 2025 | 8.59% |
| Jun 30, 2025 | -17.93% |
| Mar 31, 2025 | -37.25% |
| Dec 31, 2024 | -10.70% |
| Sep 30, 2024 | -87.29% |
| Jun 30, 2024 | -162.28% |
| Mar 31, 2024 | -63.79% |
| Dec 31, 2023 | -452.23% |
| Sep 30, 2023 | -96.84% |
| Jun 30, 2023 | -1,286.38% |
| Mar 31, 2023 | -2,742.36% |
| Dec 31, 2022 | -2,310.84% |
| Sep 30, 2022 | -14,448.00% |
API Access
Arcutis Biotherapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();